# Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

> **NCT05178524** · NA · COMPLETED · sponsor: **Tongji Hospital** · enrollment: 180 (actual)

## Conditions studied

- Gut Microbiota
- Hepatocellular Carcinoma
- Bifidobacterium

## Interventions

- **DRUG:** BIFICO

## Key facts

- **NCT ID:** NCT05178524
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05178524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05178524, "Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05178524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*